课题基金 / 基金详情

PATHOGENESIS AND IN VIVO SUPPRESSION OF THIN FILAMENT-BASED CARDIOMYOPATHIES

PATHOGENESIS AND IN VIVO SUPPRESSION OF THIN FILAMENT-BASED CARDIOMYOPATHIES
细丝型心肌病的发病机制和体内抑制
批准号:
10366554
负责人:
Anthony Cammarato
金额:
$59.5万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2015
资助国家:
美国
项目状态:
未结题
起止时间:
2015-09-01 至 2026-12-31

项目摘要

项目成果

Anthony Cammarato的其他基金

相似基金

相关文献

中文摘要
翻译
项目摘要 细丝是一种多亚基调节机。适当地调节心脏收缩需要 单个细丝蛋白之间的通讯,并控制其运动。此应用程序的目标是 是为了了解翻译后修饰(PTM)和人类心肌病突变是如何位于 细丝亚基之间的保守界面,影响蛋白质-蛋白质关联,调节肌肉 功能,和/或导致疾病。黑腹果蝇受益于强大的实验工具 对细丝扰动的最近端后果进行高效而全面的检查。这 动物模型将继续帮助我们辨别收缩调节的机制基础,更重要的是, 对分子侮辱的肌病反应。然而,老鼠在基因和生理上更类似于 人类。使用包括高速视频和低温电子显微镜在内的独特技术组合, 在电子计算机建模和力学分析中,我们将首次定义 位于细丝亚基之间的界面缝隙处的特定PTMS和心肌病突变,来自 从分子到组织水平。因此,将采用高度综合的方法,部分依赖于 一种在果蝇中表达人类肌动蛋白变体的开创性策略,用于纯化和生物物理分析,以及 基于肌动蛋白和肌钙蛋白T(TNT)的心肌病的几个新的苍蝇模型。后者将是 辅之以小鼠模型。目标1将重点确定肌动蛋白乙酰化对原肌球蛋白的影响 (TM)使用重组人蛋白、苍蝇和小鼠的定位和心脏性能。我们将测试 假设K326和K328在肌动蛋白上的乙酰化,我们之前展示的结合和帮助定向 阻止肌动球蛋白循环,阻止抑制TM定位,促进心脏 收缩。对于目标2,我们将描述某些肌动蛋白和TnT心肌病突变如何独特地影响 心肌松弛。我们将检验这样一种假设,即特定的肌动蛋白和TnT损伤干扰了不同的、关键的 界面与TM的接触,这以不同的方式改变了TM对收缩的抑制,并迫使生产 引发离散的心脏病理。对于目标3,我们将确定目标1中调查的相同的肌动蛋白PTM, 改善或加重小鼠和苍蝇心肌病模型的心肌功能障碍。我们将检验这一假设 这种由肌动蛋白假乙酰化增强的心肌收缩能力将改善和加重 扩张型和肥厚型心肌病模型的病理表型。总体而言,这项工作 具有重要意义,因为它将提供理解 细丝机正常运行,并在发病期间运行。此外,我们的努力将产生基因- 不太复杂的模型系统(果蝇)中的表型信息限制了遗传修饰物和 环境因素,以帮助建立涉及心脏重构的疾病过程的范例。
英文摘要
Project Summary The thin filament is a multi-subunit regulatory machine. Proper regulation of cardiac contraction requires communication among, and controlled movement of, individual thin filament proteins. The goal of this application is to understand how post-translational modifications (PTMs) and human cardiomyopathy mutations, located at conserved interfaces between thin filament subunits, affect protein-protein associations, modulate muscle function, and/or lead to disease. Drosophila melanogaster benefits from robust experimental tools that permit efficient, yet comprehensive, scrutiny of the most proximal consequences of thin filament perturbations. This animal model will continue to help us discern the mechanistic basis of contractile regulation and, importantly, of myopathic responses to molecular insults. Mice, however, are more genetically and physiologically similar to humans. Using a unique combination of techniques including high-speed video and cryo-electron microscopy, in silico modeling, and mechanical assays we will define, for the first time, the structural and functional effects of specific PTMs and cardiomyopathy mutations, located at interfacial seams between thin filament subunits, from the molecular to the tissue level. Therefore, a highly integrative approach will be employed that relies, in part, on a pioneering strategy to express human actin variants in Drosophila for purification and biophysical analysis, and upon several new fly models of actin and troponin T (TnT)-based cardiomyopathies. The latter will be complemented by murine models. Aim 1 will focus on determining the effects of actin acetylation on tropomyosin (Tm) positioning and cardiac performance using recombinant human proteins, flies, and mice. We will test the hypothesis that acetylation of K326 and K328 on actin, residues we previously showed bind to and help orient Tm such that it prevents actomyosin cycling, discourages inhibitory Tm positioning and promotes cardiac contraction. For Aim 2 we will delineate how certain actin and TnT cardiomyopathy mutations uniquely affect myocardial relaxation. We will test the hypothesis that particular actin and TnT lesions disturb distinct, critical interfacial contacts with Tm, which differentially alters Tm-based inhibition of contraction and force production to initiate discrete cardiac pathologies. For Aim 3, we will ascertain if the same actin PTMs investigated in Aim 1, improve or worsen myocardial dysfunction in murine and fly cardiomyopathy models. We will test the hypothesis that enhanced cardiac contractility, conferred by actin pseudo-acetylation, will improve and aggravate the pathological phenotypes in models of dilated and hypertrophic cardiomyopathy, respectively. Overall, this work is significant since it will provide critical structural and functional information necessary to understand how the thin filament machine operates normally and during disease. Additionally, our efforts will yield genotype- phenotype information in a less complex model system (Drosophila) that limits genetic modifiers and environmental factors to help establish paradigms for disease processes involved in cardiac remodeling.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Pathogenesis and in vivo suppression of thin filament based cardiomyopathies
  • 批准号:
    9302507
  • 项目类别:
  • 资助金额:
    $41.47万
  • 财政年份:
    2015
  • 负责人:
    Anthony Cammarato
  • 依托单位:
Pathogenesis and in vivo suppression of thin filament based cardiomyopathies
  • 批准号:
    9065618
  • 项目类别:
  • 资助金额:
    $39.46万
  • 财政年份:
    2015
  • 负责人:
    Anthony Cammarato
  • 依托单位:
PATHOGENESIS AND IN VIVO SUPPRESSION OF THIN FILAMENT-BASED CARDIOMYOPATHIES
  • 批准号:
    10544001
  • 项目类别:
  • 资助金额:
    $57.9万
  • 财政年份:
    2015
  • 负责人:
    Anthony Cammarato
  • 依托单位:
Pathogenesis and in vivo suppression of thin filament based cardiomyopathies
  • 批准号:
    8884895
  • 项目类别:
  • 资助金额:
    $36.67万
  • 财政年份:
    2015
  • 负责人:
    Anthony Cammarato
  • 依托单位:
海外基金